Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of August 2025. The report specifically details a transaction in the company's own shares executed under its share buyback programme.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. It focuses exclusively on share repurchase activity and capital structure updates.
- Shares Purchased: 1,369,903 ordinary shares
- Purchase Date: August 22, 2025
- Price Range: 364.20p (Low) to 368.00p (High)
- Volume Weighted Average Price: 366.7394p
- Purpose: Cancellation of shares
Material Changes
Following the settlement of the share purchase, the company's registered share capital stands at 8,969,326,205 ordinary shares of £0.01 each. Of these, 3,880,205 are held as treasury shares. Consequently, the number of ordinary shares with voting rights is 8,965,446,000.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operations, or discussion of risks and contingencies. It is a regulatory disclosure of a specific capital transaction. The announcement explicitly states it does not constitute an offer or solicitation of an offer for securities.
Key Facts for Investor Verification
- Verify the total number of voting shares (8,965,446,000) for compliance with FCA Disclosure Guidance and Transparency Rules.
- Confirm the execution of the second tranche of the buyback programme announced on July 31, 2025.
- Review the full breakdown of individual trades available via the provided London Stock Exchange link for granular pricing data.
- Note that this filing does not contain operational or financial performance metrics for the period.